LifeArc appoints Dr Linda Bradley to head up business development
Dr Linda Bradley has joined as our new Head of Business Development, effective immediately.
Congratulations @KordastiL, and @kazemianlab, @LionakisLab, @CWobus, Kemper lab, @OlsonLabPU et al, on publishing t… https://t.co/s5wQUaDpwW
KQ Labs announces the graduation of its third cohort in a highly successful Demo Day event
KQ Labs will be opening its next cohort for applications in early May 2021
LifeArc and Action Medical Research announce commitment of over £1m to research into rare diseases in children
Demonstrates our focus on improving the lives of people living with rare diseases.
LifeArc provides £5 million funding to increase understanding of the role of genetic risk factors in patient response to COVID-19
February 15, 2021: Medical research charity, LifeArc, announces today that it is providing £5 million funding to…
LifeArc invests £10 million in Illumina Accelerator to Advance Genomics Startups
London, February 8, 2021: LifeArc announced today a £10 million cornerstone investment in the funding cycle of…
LifeArc working with the Crohn’s & Colitis Foundation to develop a prognostic test for Crohn’s disease in children
A new partnership between LifeArc and the US-based Crohn’s & Colitis Foundation (Foundation) aims to progress encouraging…
Metrion Biosciences and LifeArc further extend neuroscience-focused ion channel drug discovery collaboration
Ongoing collaboration extended for another 12 months and successfully progresses into late stage hit-to-lead optimisation phase Cambridge…
LifeArc funds COVID-19 drug screening hub at the University of Glasgow
A new COVID-19 drug screening and resistance hub will be established in Scotland, based at the MRC-University…
LifeArc co-leads £6 million funding in DJS Antibodies
LifeArc announces Seed Fund investment of £2 million in DJS Antibodies, a biotech start-up company pioneering the…